134 related articles for article (PubMed ID: 30599849)
1. Effects of menstrual cycle on background parenchymal enhancement and detectability of breast cancer on dynamic contrast-enhanced breast MRI: A multicenter study of an Asian population.
Kamitani T; Yabuuchi H; Kanemaki Y; Tozaki M; Sonomura T; Mizukoshi W; Nakata W; Shimono T; Urano M; Yamano T; Kato F; Kuchiki M; Shiragami N; Yanagita H; Katsuda E; Kataoka M; Yamaguchi K; Horikoshi T; Gomi T; Nozaki M; Shiotani M; Amano M; Saigusa H; Sadaoka S; Kamiya H; Kubo M; Yamashita N; Yamamoto H; Honda H
Eur J Radiol; 2019 Jan; 110():130-135. PubMed ID: 30599849
[TBL] [Abstract][Full Text] [Related]
2. Effect of the menstrual cycle on background parenchymal enhancement in breast MR imaging.
Kajihara M; Goto M; Hirayama Y; Okunishi S; Kaoku S; Konishi E; Shinkura N
Magn Reson Med Sci; 2013 Mar; 12(1):39-45. PubMed ID: 23474960
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Association Between Menstrual Cycle Timing and Quantitative Background Parenchymal Enhancement on Breast MRI in Premenopausal Women.
He Y; Zhou J; Liu X; Wei Y; Ye S; Miao H; Liu H; Chen Z; Zhao Y; Wang M
Clin Breast Cancer; 2023 Oct; 23(7):e451-e457.e1. PubMed ID: 37640598
[TBL] [Abstract][Full Text] [Related]
4. Effects of gadobutrol on background parenchymal enhancement and differential diagnosis between benign and malignant lesions in dynamic magnetic resonance imaging of the breast.
Tozaki M; Yabuuchi H; Goto M; Sasaki M; Kubota K; Nakahara H
Breast Cancer; 2021 Jul; 28(4):927-936. PubMed ID: 33625722
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of background parenchymal enhancement in whole breast on MRI: Influence of menstrual cycle and comparison with a qualitative analysis.
Jung Y; Jeong SK; Kang DK; Moon Y; Kim TH
Eur J Radiol; 2018 Jun; 103():84-89. PubMed ID: 29803391
[TBL] [Abstract][Full Text] [Related]
6. Association of Clinical Factors and Degree of Early Background Parenchymal Enhancement on Contrast-Enhanced Mammography.
Wang S; Sun Y; You C; Jiang T; Yang M; Shen X; Qian M; Duan S; Lynn HS; Li R; Gu Y
AJR Am J Roentgenol; 2023 Jul; 221(1):45-55. PubMed ID: 36695647
[No Abstract] [Full Text] [Related]
7. Pilot study of quantitative analysis of background enhancement on breast MR images: association with menstrual cycle and mammographic breast density.
Scaranelo AM; Carrillo MC; Fleming R; Jacks LM; Kulkarni SR; Crystal P
Radiology; 2013 Jun; 267(3):692-700. PubMed ID: 23418005
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging.
Sogani J; Morris EA; Kaplan JB; D'Alessio D; Goldman D; Moskowitz CS; Jochelson MS
Radiology; 2017 Jan; 282(1):63-73. PubMed ID: 27379544
[TBL] [Abstract][Full Text] [Related]
9. Physiologic changes in breast magnetic resonance imaging during the menstrual cycle: perfusion imaging, signal enhancement, and influence of the T1 relaxation time of breast tissue.
Delille JP; Slanetz PJ; Yeh ED; Kopans DB; Garrido L
Breast J; 2005; 11(4):236-41. PubMed ID: 15982388
[TBL] [Abstract][Full Text] [Related]
10. Factors Associated With Background Parenchymal Enhancement on Contrast-Enhanced Mammography.
Karimi Z; Phillips J; Slanetz P; Lotfi P; Dialani V; Karimova J; Mehta T
AJR Am J Roentgenol; 2021 Feb; 216(2):340-348. PubMed ID: 32755162
[No Abstract] [Full Text] [Related]
11. Background Parenchymal Enhancement on Contrast-Enhanced Spectral Mammography: Influence of Age, Breast Density, Menstruation Status, and Menstrual Cycle Timing.
Zhao S; Zhang X; Zhong H; Qin Y; Li Y; Song B; Huang J; Yu J
Sci Rep; 2020 May; 10(1):8608. PubMed ID: 32451404
[TBL] [Abstract][Full Text] [Related]
12. Background parenchymal enhancement on breast MRI: influence of menstrual cycle and breast composition.
Kang SS; Ko EY; Han BK; Shin JH; Hahn SY; Ko ES
J Magn Reson Imaging; 2014 Mar; 39(3):526-34. PubMed ID: 23633296
[TBL] [Abstract][Full Text] [Related]
13. Should breast MRI be performed with adjustment for the phase in patients' menstrual cycle? Correlation between mammographic density, age, and background enhancement on breast MRI without adjusting for the phase in patients' menstrual cycle.
Uematsu T; Kasami M; Watanabe J
Eur J Radiol; 2012 Jul; 81(7):1539-42. PubMed ID: 21592704
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of background parenchymal enhancement in breast contrast-enhanced ultrasound with Sonazoid
Haga M; Hirai T; Nakai T; Kobayashi T; Nakamura T; Marugami A; Ito T; Takewa M; Marugami N; Kichikawa K
J Med Ultrason (2001); 2020 Oct; 47(4):591-601. PubMed ID: 32989596
[TBL] [Abstract][Full Text] [Related]
15. Background parenchymal enhancement and its effect on lesion detectability in ultrafast dynamic contrast-enhanced MRI.
Honda M; Kataoka M; Iima M; Miyake KK; Ohashi A; Kishimoto AO; Ota R; Nickel MD; Toi M; Togashi K
Eur J Radiol; 2020 Aug; 129():108984. PubMed ID: 32534350
[TBL] [Abstract][Full Text] [Related]
16. Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type.
Dilorenzo G; Telegrafo M; La Forgia D; Stabile Ianora AA; Moschetta M
Eur J Radiol; 2019 Apr; 113():148-152. PubMed ID: 30927939
[TBL] [Abstract][Full Text] [Related]
17. Effect of Background Parenchymal Enhancement on Cancer Risk Across Different High-Risk Patient Populations Undergoing Screening Breast MRI.
Sippo DA; Rutledge GM; Burk KS; Mercaldo SF; Dontchos BN; Edmonds CE; Lehman CD
AJR Am J Roentgenol; 2019 Mar; 212(6):1412-1418. PubMed ID: 30888867
[TBL] [Abstract][Full Text] [Related]
18. Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study.
Watt GP; Sung J; Morris EA; Buys SS; Bradbury AR; Brooks JD; Conant EF; Weinstein SP; Kontos D; Woods M; Colonna SV; Liang X; Stein MA; Pike MC; Bernstein JL
Breast Cancer Res; 2020 Dec; 22(1):138. PubMed ID: 33287857
[TBL] [Abstract][Full Text] [Related]
19. Background parenchymal enhancement in pregnancy-associated breast cancer: a hindrance to diagnosis?
Taron J; Fleischer S; Preibsch H; Nikolaou K; Gruber I; Bahrs S
Eur Radiol; 2019 Mar; 29(3):1187-1193. PubMed ID: 30229271
[TBL] [Abstract][Full Text] [Related]
20. Analysis of factors influencing the degree of detectability on diffusion-weighted MRI and diffusion background signals in patients with invasive breast cancer.
Hahn SY; Ko ES; Han BK; Lim Y; Gu S; Ko EY
Medicine (Baltimore); 2016 Jul; 95(27):e4086. PubMed ID: 27399100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
